Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Head and Neck Cancer

Free Subscription 23.05.2022 6 Ann Otol Rhinol Laryngol 2 Ann Surg 1 Ann Thorac Surg 5 BMC Cancer 4 BMC Surg 1 Br J Oral Maxillofac Surg 1 Cancer 4 Dis Esophagus 1 Head Neck 1 HNO 1 Int J Pediatr Otorhinolaryngol 5 Int J Radiat Oncol Biol Phys 5 J Clin Endocrinol Metab 1 J Clin Oncol 1 J Nucl Med 7 Laryngoscope 4 Ophthalmic Plast Reconstr Surg 9 Oral Oncol 5 PLoS One 2 Radiol Imaging Cancer 7 Radiother Oncol 11 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Otol Rhinol Laryngol

1. BENYO S, Phan C, Goyal N
   Health and Well-Being Needs Among Head and Neck Cancer Caregivers - A Systematic Review.
   Ann Otol Rhinol Laryngol. 2022 May 12:34894221088180.
   PubMed         Abstract available
   
   
2. FUJIKI RB, Sanders PW, Sivasankar MP, Halum S, et al
   Determining Medical Urgency of Voice Disorders Using Auditory-Perceptual Voice Assessments Performed by Speech-Language Pathologists.
   Ann Otol Rhinol Laryngol. 2021 Jul 20:34894211032779.
   PubMed         Abstract available
   
   
3. MATHEWS F, Irizarry R, Rosenfeld R, Sundaram K, et al
   Systematic Review and Meta-Analysis of Post-Treatment PET/CT in HPV-Associated Oropharyngeal Cancer.
   Ann Otol Rhinol Laryngol. 2022;131:595-603.
   PubMed         Abstract available
   
   
4. WEEKS KS, Lynch CF, Pagedar N
   Trends in Cancer Treatment for Oral Cavity, Oropharynx, and Larynx in 2016 Versus 2009: SEER Patterns of Care Studies.
   Ann Otol Rhinol Laryngol. 2022;131:629-639.
   PubMed         Abstract available
   
   
5. CHEN MM, Chang CM, Dermody S, Rosko AJ, et al
   A Consideration for Surgical Management in Select T4b Oral Cavity Squamous Cell Carcinoma.
   Ann Otol Rhinol Laryngol. 2022;131:609-616.
   PubMed         Abstract available
   
   
6. WU TJ, Saggi S, Badran KW, Han AY, et al
   Radial Forearm Free Flap Reconstruction of Glossectomy Defects Without Tracheostomy.
   Ann Otol Rhinol Laryngol. 2022;131:655-661.
   PubMed         Abstract available
   
   

   
   Ann Surg

7. FRANSEN LFC, Janssen THJB, Aarnoudse M, Nieuwenhuijzen GAP, et al
   Direct Oral Feeding After a Minimally Invasive Esophagectomy: A Single-Center Prospective Cohort Study.
   Ann Surg. 2022;275:919-923.
   PubMed         Abstract available
   
   
8. CLAASSEN L, Hannink G, Luyer MDP, Ainsworth AP, et al
   Learning Curves of Ivor Lewis Totally Minimally Invasive Esophagectomy by Hospital and Surgeon Characteristics: A Retrospective Multinational Cohort Study.
   Ann Surg. 2022;275:911-918.
   PubMed         Abstract available
   
   

   
   Ann Thorac Surg

9. TAKATSU F, Suzawa K, Okazaki M, Shien K, et al
   Clinical features of patients with second primary lung cancer following head and neck cancer.
   Ann Thorac Surg. 2022 May 17. pii: S0003-4975(22)00705.
   PubMed         Abstract available
   
   

   
   BMC Cancer

10. LIN C, Li M, Lin N, Zong J, et al
    RNF38 suppress growth and metastasis via ubiquitination of ACTN4 in nasopharyngeal carcinoma.
    BMC Cancer. 2022;22:549.
    PubMed         Abstract available
    
    
11. QIAN L, Ni T, Fei B, Sun H, et al
    An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma.
    BMC Cancer. 2022;22:545.
    PubMed         Abstract available
    
    
12. HUO Z, Fu S, Ma C, Sheng S, et al
    Level IV neck dissection in cN0 HPV-negative oropharyngeal squamous cell carcinoma: a retrospective cohort study.
    BMC Cancer. 2022;22:535.
    PubMed         Abstract available
    
    
13. DOS SANTOS M, Lequesne J, Leconte A, Corbinais S, et al
    Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR).
    BMC Cancer. 2022;22:537.
    PubMed         Abstract available
    
    
14. CAI M, Zheng Z, Bai Z, Ouyang K, et al
    Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers.
    BMC Cancer. 2022;22:530.
    PubMed         Abstract available
    
    

    
    BMC Surg

15. BERTLICH M, Zeller N, Freytag S, Spiegel JL, et al
    Factors influencing outcomes in selective neck dissection in 661 patients with head and neck squamous cell carcinoma.
    BMC Surg. 2022;22:196.
    PubMed         Abstract available
    
    
16. SHIGENO T, Hoshino A, Matsunaga S, Shimano R, et al
    The impact of lymphadenectomy on lymph node recurrence after performing various treatments for esophageal squamous cell carcinoma.
    BMC Surg. 2022;22:171.
    PubMed         Abstract available
    
    
17. HE Q, Zhu J, Li X, Wang M, et al
    A comparative study of two robotic thyroidectomy procedures: transoral vestibular versus bilateral axillary-breast approach.
    BMC Surg. 2022;22:173.
    PubMed         Abstract available
    
    
18. SAGAWA H, Saito M, Ito S, Hayakawa S, et al
    Near infrared ray-guided surgery using Firefly technology of the daVinci Xi system and intraoperative upper gastrointestinal endoscopy for subtotal gastrectomy and surgery for cancer of the gastroesophageal junction.
    BMC Surg. 2022;22:174.
    PubMed         Abstract available
    
    

    
    Br J Oral Maxillofac Surg

19. KOSTAKIS G, Perisanidis C, Koumaki D, Papadopoulos P, et al
    Unilateral saggital split osteotomy - A technical note for treating oral cancer.
    Br J Oral Maxillofac Surg. 2022 Apr 27. pii: S0266-4356(22)00129.
    PubMed        
    
    

    
    Cancer

20. HUANG SH, Jacinto JCK, O'Sullivan B, Su J, et al
    Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort.
    Cancer. 2022 May 19. doi: 10.1002/cncr.34266.
    PubMed         Abstract available
    
    

    
    Dis Esophagus

21. WESTRA WM, Straub D, Milano F, Buttar NS, et al
    Inhibition of the BMP pathway prevents development of Barrett's-associated adenocarcinoma in a surgical rat model.
    Dis Esophagus. 2022;35.
    PubMed         Abstract available
    
    
22. STEPHANIE M, Nour H, de Sa Ines M, Shanker K, et al
    Gender differences in Barrett's esophagus and progression of disease: a systematic review and meta-analysis.
    Dis Esophagus. 2022;35.
    PubMed         Abstract available
    
    
23. ISHIKAWA Y, Breuler C, Chang AC, Lin J, et al
    Quantitative perfusion assessment of gastric conduit with indocyanine green dye to predict anastomotic leak after esophagectomy.
    Dis Esophagus. 2022;35.
    PubMed         Abstract available
    
    
24. GENERE JR, Visrodia K, Zakko L, Hoefnagel SJM, et al
    Spray cryotherapy versus continued radiofrequency ablation in persistent Barrett's esophagus.
    Dis Esophagus. 2022;35.
    PubMed         Abstract available
    
    

    
    Head Neck

25. LEE J, Lee JJB, Cha IH, Park KR, et al
    Risk factor analysis of dental implants in patients with irradiated head and neck cancer.
    Head Neck. 2022 May 12. doi: 10.1002/hed.27080.
    PubMed         Abstract available
    
    

    
    HNO

26. DYCKHOFF G, Warta R, Herold-Mende C, Plinkert PK, et al
    [Larynx preservation: recommendations for decision-making in T3 laryngeal cancer patients].
    HNO. 2022 May 16. pii: 10.1007/s00106-022-01177.
    PubMed         Abstract available
    
    

    
    Int J Pediatr Otorhinolaryngol

27. NEWFIELD RS, Jiang W, Sugganth DX, Hantash FM, et al
    Mutational analysis using next generation sequencing in pediatric thyroid cancer reveals BRAF and fusion oncogenes are common.
    Int J Pediatr Otorhinolaryngol. 2022;157:111121.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

28. TAYLOR CL, Price JM
    The Tooth Hurts: Dental Health After Radiation Therapy for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2022;113:331-334.
    PubMed        
    
    
29. MCDOWELL L, Chua MLK, Beadle BM, Ma DJ, et al
    A Bit More Here and a Little Less There: The Trials (and Tribulations) of Adjuvant and Neoadjuvant Head and Neck Studies in 2021.
    Int J Radiat Oncol Biol Phys. 2022;113:243-251.
    PubMed        
    
    
30. CARDENAS CE, Blinde SE, Mohamed ASR, Ng SP, et al
    Comprehensive Quantitative Evaluation of Variability in Magnetic Resonance-Guided Delineation of Oropharyngeal Gross Tumor Volumes and High-Risk Clinical Target Volumes: An R-IDEAL Stage 0 Prospective Study.
    Int J Radiat Oncol Biol Phys. 2022;113:426-436.
    PubMed         Abstract available
    
    
31. SCHRODER C, Kothe A, De Angelis C, Basler L, et al
    NTCP Modeling for High-Grade Temporal Radionecroses in a Large Cohort of Patients Receiving Pencil Beam Scanning Proton Therapy for Skull Base and Head and Neck Tumors.
    Int J Radiat Oncol Biol Phys. 2022;113:448-455.
    PubMed         Abstract available
    
    
32. LIU X, Guo L, Xie FY, Hu WH, et al
    Necrosis in a Biomarker-driven, Phase 2 Trial of Adjuvant Apatinib in Patients of Nasopharyngeal Carcinoma with Residual Epstein-Barr Virus DNA after Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2022 May 9. pii: S0360-3016(22)00410.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

33. GREEN M, Gosmanov AR
    Letter to the Editor From Green and Gosmanov: "Tall Cell Percentage Alone in PTC Without Aggressive Features Should Not Guide Patients' Clinical Management".
    J Clin Endocrinol Metab. 2022;107:e2647-e2648.
    PubMed        
    
    
34. VIOLA D, Poma AM, Elisei R, Basolo F, et al
    Response to Letter to the Editor From Green and Gosmanov: "Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients' Clinical Management".
    J Clin Endocrinol Metab. 2022;107:e2653-e2654.
    PubMed        
    
    
35. GLASGOW C, Lau EYC, Aloj L, Harper I, et al
    An Approach to a Patient With Primary Hyperparathyroidism and a Suspected Ectopic Parathyroid Adenoma.
    J Clin Endocrinol Metab. 2022;107:1706-1713.
    PubMed         Abstract available
    
    
36. WENG HY, Yan T, Qiu WW, Fan YB, et al
    The prognosis of skip metastasis in papillary thyroid microcarcinoma is better than that of continuous metastasis.
    J Clin Endocrinol Metab. 2022 Feb 25. pii: 6537119. doi: 10.1210.
    PubMed         Abstract available
    
    
37. BOUCAI L, Tuttle RM
    Letter to the Editor from Boucai, L and Tuttle, RM: "BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer".
    J Clin Endocrinol Metab. 2022 Mar 9. pii: 6545312. doi: 10.1210.
    PubMed        
    
    

    
    J Clin Oncol

38. GUPTA T, Maheshwari G, Kannan S, Nair S, et al
    Should Sentinel Lymph Node Biopsy Be Considered the New Standard of Care for Early-Stage Clinically Node-Negative Oral Squamous Cell Carcinoma?
    J Clin Oncol. 2022;40:1706-1709.
    PubMed        
    
    

    
    J Nucl Med

39. SUBRAMANIAM RM, Duan F, Romanoff J, Yu JQ, et al
    (18)F FDG PET/CT Staging of Head and Neck Cancer: Inter-observer agreement and accuracy - Results from multicenter ACRIN 6685 Clinical Trial.
    J Nucl Med. 2022 May 12. pii: jnumed.122.263902. doi: 10.2967/jnumed.122.263902.
    PubMed         Abstract available
    
    

    
    Laryngoscope

40. HAIMOWITZ S, Cohen DA, Dhanda A, Barron K, et al
    Mucosal Melanoma of the Oral Cavity: What is the Role of Elective Neck Dissection?
    Laryngoscope. 2022 May 13. doi: 10.1002/lary.30152.
    PubMed         Abstract available
    
    
41. SAKTHIVEL P, Kamaleshwaran KK, Thakar A, Kumar R, et al
    In Reference to Functional Imaging in Juvenile Angiofibroma.
    Laryngoscope. 2022;132:E25.
    PubMed        
    
    
42. SCHREIBER A, Mattavelli D, Ravanelli M, Rampinelli V, et al
    In Response to Early Functional Imaging in Juvenile Angiofibroma.
    Laryngoscope. 2022;132:E23-E24.
    PubMed        
    
    
43. WU MP, Reinshagen KL, Cunnane MB, Shalhout SZ, et al
    Clinical Perineural Invasion and Immunotherapy for Head and Neck Cutaneous Squamous Cell Carcinoma.
    Laryngoscope. 2022;132:1213-1218.
    PubMed         Abstract available
    
    
44. BIGNAMI M, Pietrobon G, Arosio AD, Fazio E, et al
    Juvenile Angiofibroma: What Is on Stage?
    Laryngoscope. 2022;132:1160-1165.
    PubMed         Abstract available
    
    
45. SLIJEPCEVIC AA, Roh J, Pipkorn P, Lipsey K, et al
    Carotid Blowout Syndrome in Head and Neck Cancer Patients: Management of Patients At Risk for CBS.
    Laryngoscope. 2022 May 16. doi: 10.1002/lary.30157.
    PubMed         Abstract available
    
    
46. PANUGANTI BA, Voora R, Coffey C, Orosco R, et al
    Transoral Laser Microsurgery With Neck Dissection Versus Radiotherapy for T2N0 Supraglottic Cancer.
    Laryngoscope. 2022 May 12. doi: 10.1002/lary.30171.
    PubMed         Abstract available
    
    

    
    Ophthalmic Plast Reconstr Surg

47. CUSTER PL, Maamari RN
    The Kollner Tarsoconjunctival Flap for Lower Eyelid Reconstruction: Historical Perspective and Surgical Outcomes of 140 Cases.
    Ophthalmic Plast Reconstr Surg. 2021 Nov 22. pii: 00002341-900000000-97767.
    PubMed         Abstract available
    
    
48. BOHNAK CE, Dempsey KS, Harmsen HJ, Law JJ, et al
    Mucoepidermoid Carcinoma of the Eyelid in an Adolescent.
    Ophthalmic Plast Reconstr Surg. 2022;38:307-309.
    PubMed        
    
    
49. PATEL N, Alabiad CR, Wick MR, Elgart GW, et al
    Squamoid Eccrine Ductal Carcinoma of the Eyelid: Clinicopathologic Correlation of a Case.
    Ophthalmic Plast Reconstr Surg. 2022;38:e80-e82.
    PubMed         Abstract available
    
    
50. BERGGREN JV, Tenland K, Sheikh R, Hult J, et al
    Laser Speckle Contrast Imaging of the Blood Perfusion in Glabellar Flaps Used to Repair Medial Canthal Defects.
    Ophthalmic Plast Reconstr Surg. 2022;38:274-279.
    PubMed         Abstract available
    
    

    
    Oral Oncol

51. BALACHANDER K, Paramasivam A
    Mitophagy: A therapeutic target for oral squamous cell carcinoma.
    Oral Oncol. 2022;129:105881.
    PubMed        
    
    
52. FERRELI F, Pirola F, Di Santo D, De Virgilio A, et al
    A critical analysis of the classifications of squamous cell carcinoma of the nasal vestibule.
    Oral Oncol. 2022;129:105880.
    PubMed        
    
    
53. PAQUIN R, Gill B, Martin E, Byrd JK, et al
    Base of tongue neuroendocrine carcinoma: A case report.
    Oral Oncol. 2022;129:105780.
    PubMed         Abstract available
    
    
54. YANG X, Song H, Ji T, Du G, et al
    The implications of gene mutations in salivary DNA for noninvasive diagnosis of head and neck cancer with a focus on oral cancer.
    Oral Oncol. 2022;130:105924.
    PubMed         Abstract available
    
    
55. FORNER D, Mok F, Verma N, Karam I, et al
    Placement technique impacts gastrostomy tube-related complications amongst head and neck cancer patients.
    Oral Oncol. 2022;130:105903.
    PubMed         Abstract available
    
    
56. PAZHANI J, Jayaraman S, Veeraraghavan VP, Somasundaram DB, et al
    Targeting cancer associated fibroblasts - A TGF-beta based immunotherapy for head and neck squamous cell carcinoma.
    Oral Oncol. 2022;130:105899.
    PubMed        
    
    
57. JIANG Y, Yang S, Qi Y
    Comment on: The prognostic value of radiologic extranodal extension in nasopharyngeal carcinoma: Systematic review and meta-analysis.
    Oral Oncol. 2022;130:105872.
    PubMed        
    
    
58. LEBOUCHER A, Sotton S, Gambin Flandrin I, Magne N, et al
    Head and neck radiotherapy-induced carotid toxicity: Pathophysiological concepts and clinical syndromes.
    Oral Oncol. 2022;129:105868.
    PubMed         Abstract available
    
    
59. VIJAYASHREE PRIYADHARSINI J, Anitha P
    Quantitative malignant index diagnosis system (qMIDS) for effective diagnosis of oral premalignant lesions.
    Oral Oncol. 2022;129:105902.
    PubMed        
    
    

    
    PLoS One

60. ZHANG Z, Leong Bin Abdullah MFI, Shari NI, Lu P, et al
    Acceptance and commitment therapy versus mindfulness-based stress reduction for newly diagnosed head and neck cancer patients: A randomized controlled trial assessing efficacy for positive psychology, depression, anxiety, and quality of life.
    PLoS One. 2022;17:e0267887.
    PubMed         Abstract available
    
    
61. ADNAN Y, Ali SMA, Awan MS, Idress R, et al
    Hormone receptors AR, ER, PR and growth factor receptor Her-2 expression in oral squamous cell carcinoma: Correlation with overall survival, disease-free survival and 10-year survival in a high-risk population.
    PLoS One. 2022;17:e0267300.
    PubMed         Abstract available
    
    
62. CHANGKUN Z, Bishwajit G, Ji L, Tang S, et al
    Sociodemographic correlates of cervix, breast and oral cancer screening among Indian women.
    PLoS One. 2022;17:e0265881.
    PubMed         Abstract available
    
    
63. MIAO L, Lv X, Huang C, Li P, et al
    Long-term oncological outcomes after oral cancer surgery using propofol-based total intravenous anesthesia versus sevoflurane-based inhalation anesthesia: A retrospective cohort study.
    PLoS One. 2022;17:e0268473.
    PubMed         Abstract available
    
    
64. BROUWER AF, Campredon LP, Walline HM, Marinelli BM, et al
    Prevalence and determinants of oral and cervicogenital HPV infection: Baseline analysis of the Michigan HPV and Oropharyngeal Cancer (MHOC) cohort study.
    PLoS One. 2022;17:e0268104.
    PubMed         Abstract available
    
    

    
    Radiol Imaging Cancer

65. BEDMUTHA A, Kaushal A
    Pseudoprogression during Immunotherapy in Metastatic Head and Neck Squamous Cell Carcinoma.
    Radiol Imaging Cancer. 2022;4:e220037.
    PubMed        
    
    
66. LIN EP, Chin BB, Fishbein L, Moritani T, et al
    Head and Neck Paragangliomas: An Update on the Molecular Classification, State-of-the-Art Imaging, and Management Recommendations.
    Radiol Imaging Cancer. 2022;4:e210088.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

67. BIAU J, Nutting C, Langendijk JA, Frederic-Moreau T, et al
    Radiographic-anatomy, natural history and extension pathways of parotid and submandibular gland cancers.
    Radiother Oncol. 2022;170:48-54.
    PubMed         Abstract available
    
    
68. SOOKAROMDEE P, Wiwanitkit V
    Comment on "Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC".
    Radiother Oncol. 2022;170:250.
    PubMed        
    
    
69. LOCK S, Baumann M
    Response to comment on "Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC".
    Radiother Oncol. 2022;170:251.
    PubMed        
    
    
70. PERGOLIZZI S, Ferini G, Parisi S
    Letter to the editor of radiotherapy and oncology regarding of the paper "Stereotactic body radiotherapy for head and neck skin cancer" by IS Voruganti et al.
    Radiother Oncol. 2022;170:247.
    PubMed        
    
    
71. KARAM I, Voruganti IS, Poon I
    Response letter to the Editor of Radiotherapy and Oncology regarding the paper "Stereotactic body radiotherapy for head and neck skin cancer" by IS Voruganti et al.
    Radiother Oncol. 2022;170:248-249.
    PubMed        
    
    
72. ZHAO DW, Fan WJ, Fang XM, Luo YR, et al
    Sparing submandibular gland to alleviating acute xerostomia in patients with nasopharyngeal carcinoma treated with helical tomotherapy: Evaluation by diffusion kurtosis imaging.
    Radiother Oncol. 2022 May 15. pii: S0167-8140(22)00251.
    PubMed         Abstract available
    
    
73. YI-LIANG SHEN E, Hung TM, Tsan DL, Cheng NM, et al
    Utilization of the lymph node-to-primary tumor ratio of PET standardized uptake value and circulating epstein-barr virus DNA to predict distant metastasis in nasopharyngeal carcinoma.
    Radiother Oncol. 2022 May 11. pii: S0167-8140(22)00240.
    PubMed         Abstract available
    
    

    
    Thyroid

74. CAPDEVILA J, Klochikhin A, Leboulleux S, Isaev P, et al
    A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg per Day Compared with the Cabozantinib Capsule at 140 mg per Day in Patients With Progressive, Metastatic Medullary Thyroid Cancer.
    Thyroid. 2022 Apr 10. doi: 10.1089/thy.2022.0027.
    PubMed         Abstract available
    
    
75. HATASHIMA A, Archambeau B, Armbruster H, Xu M, et al
    An Evaluation of Clinical Efficacy of Immune Checkpoint Inhibitors for Patients with Anaplastic Thyroid Carcinoma.
    Thyroid. 2022 May 18. doi: 10.1089/thy.2022.0073.
    PubMed         Abstract available
    
    
76. LEE JY, Woo KI
    Surgical risk prediction for nasolacrimal duct obstruction in radioactive iodine treated thyroid cancer: A nationwide cohort study.
    Thyroid. 2021 Dec 12. doi: 10.1089/thy.2021.0418.
    PubMed         Abstract available
    
    
77. LIWEN L, Xinguang Q
    Safety and efficacy of ultrasound-guided radiofrequency ablation for benign nonfunctional thyroid nodules in children: a retrospective study of 62 patients with over 4 years of follow-up.
    Thyroid. 2021 Dec 16. doi: 10.1089/thy.2021.0454.
    PubMed         Abstract available
    
    
78. MEGWALU U, Moon PK
    Thyroid Cancer Incidence and Mortality Trends in the United States: 2000 - 2018.
    Thyroid. 2022 Feb 8. doi: 10.1089/thy.2021.0662.
    PubMed         Abstract available
    
    
79. GROUSSIN L, Theodon H, Bessiene L, Bricaire L, et al
    Redifferentiating effect of larotrectinib in NTRK-rearranged advanced radioactive-iodine refractory thyroid cancer.
    Thyroid. 2022 Feb 16. doi: 10.1089/thy.2021.0524.
    PubMed         Abstract available
    
    
80. JONKLAAS J
    Impact of Nasolacrimal Dysfunction in Thyroid Cancer Survivors.
    Thyroid. 2022 Feb 18. doi: 10.1089/thy.2022.0095.
    PubMed         Abstract available
    
    
81. HSIAO V, Arroyo N, Fernandes-Taylor S, Chiu AS, et al
    Sensitivity of Palpation for Detection of Thyroid Nodules with Attention to Size.
    Thyroid. 2022 Feb 25. doi: 10.1089/thy.2021.0692.
    PubMed         Abstract available
    
    
82. SUZUKI N, Watanabe N, Noh JY, Yoshimura R, et al
    The relationship between primary thyroid lymphoma and various types of thyroid autoimmunity: A retrospective cohort study of 498 cases, including 9 cases with Graves' disease.
    Thyroid. 2022 Mar 1. doi: 10.1089/thy.2021.0613.
    PubMed         Abstract available
    
    
83. ZHANG F, Teng D, Tong N, Wang G, et al
    Gender-Specific Associations Between Metabolic Disorders and Thyroid Nodules: A Cross-Sectional Population-Based Study From China.
    Thyroid. 2022 Mar 23. doi: 10.1089/thy.2021.0686.
    PubMed         Abstract available
    
    
84. WANG Z, Tang C, Wang Y, Yin Z, et al
    Inclusion of the Number of Metastatic Lymph Nodes in the Staging System for Medullary Thyroid Cancer: Validating a Modified AJCC TNM Staging System.
    Thyroid. 2022 Mar 30. doi: 10.1089/thy.2021.0571.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: